Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HealthEquity (HQY)

HealthEquity Adds Sanford Health CEO Bill Gassen to Board of Directors

Neutral Impact 2 of 5 leadership Written later

HealthEquity appointed William Gassen, president and CEO of Sanford Health, to its board effective March 26, 2026, expanding the board from nine to ten members. The filing also discloses that Sanford Health is a customer, with $123,923 in revenue to HealthEquity in the fiscal year ended January 31, 2026, and expected revenue above $120,000 in the fiscal year ending January 31, 2027.

Key points

  • Gassen joins the board effective March 26, 2026, and will serve on the Audit and Risk Committee and the Talent, Compensation and Culture Committee.
  • The board expanded to ten members from nine; the company says eight of the ten directors are independent.
  • HealthEquity received $123,923 from Sanford Health in the fiscal year ended January 31, 2026, and expects more than $120,000 in the fiscal year ending January 31, 2027.

The filing

CompanyHealthEquity (HQY)
Form8-K, current report
Filed with the SECMar 30, 2026, 5:38 PM ET
Accession number0001428336-26-000012

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 30, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.